US 11,690,883 B2
Lactobacillus acidophilus TW01 isolate and use thereof
Hsin-Hua Chiang, Kaohsiung (TW); and Bo-Jyun Liou, Kaohsiung (TW)
Assigned to I EATING LIGHT LTD., Kaohsiung (TW)
Filed by I EATING LIGHT LTD., Kaohsiung (TW)
Filed on May 4, 2022, as Appl. No. 17/736,387.
Claims priority of application No. 110116826 (TW), filed on May 10, 2021.
Prior Publication US 2022/0370524 A1, Nov. 24, 2022
Int. Cl. A61K 35/747 (2015.01); A23L 33/135 (2016.01); C12R 1/23 (2006.01); A23L 33/00 (2016.01)
CPC A61K 35/747 (2013.01) [A23L 33/135 (2016.08); A23L 33/40 (2016.08); A23V 2002/00 (2013.01); A23V 2200/32 (2013.01); A23V 2200/324 (2013.01); A23Y 2220/03 (2013.01); C12R 2001/23 (2021.05)] 7 Claims
OG exemplary drawing
 
1. A method for alleviating an inflammation-related disorder, comprising administering to a subject in need thereof a composition including an isolated strain of Lactobacillus acidophilus TW01,
wherein the isolated strain of Lactobacillus acidophilus TW01 is deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under an accession number DSM 33990.